JYNT Quote, Financials, Valuation and Earnings

CVS Health Corp. has a net margin of 2.17% compared to The Joint Corp. (United States)'s net margin of -3.88%. The Joint Corp. (United States)'s return on equity of -1.38% beat CVS Health Corp.'s return on equity of 0.57%.

The Joint Corp. (United States) has a consensus price target of $10.67, signalling upside risk potential of 22.32%. On the other hand CVS Health Corp. has an analysts' consensus of $94.33 which suggests that it could grow by 19.2%. Given that The Joint Corp. (United States) has higher upside potential than CVS Health Corp., analysts believe The Joint Corp. (United States) is more attractive than CVS Health Corp..

The Joint Corp. (United States) has a beta of 1.291, which suggesting that the stock is 29.096% more volatile than S&P 500. In comparison CVS Health Corp. has a beta of 0.486, suggesting its less volatile than the S&P 500 by 51.445%.

The Joint Corp. (United States) has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CVS Health Corp. offers a yield of 3.35% to investors and pays a quarterly dividend of $0.67 per share. The Joint Corp. (United States) pays -- of its earnings as a dividend. CVS Health Corp. pays out 72.76% of its earnings as a dividend. CVS Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

The Joint Corp. (United States) quarterly revenues are $13.4M, which are smaller than CVS Health Corp. quarterly revenues of $102.9B. The Joint Corp. (United States)'s net income of $290.4K is higher than CVS Health Corp.'s net income of -$4B. Notably, The Joint Corp. (United States)'s price-to-earnings ratio is 75.63x while CVS Health Corp.'s PE ratio is 207.42x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Joint Corp. (United States) is 2.44x versus 0.26x for CVS Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Enhabit, Inc. has a net margin of 2.17% compared to The Joint Corp. (United States)'s net margin of 4.4%. The Joint Corp. (United States)'s return on equity of -1.38% beat Enhabit, Inc.'s return on equity of -1.74%.

The Joint Corp. (United States) has a consensus price target of $10.67, signalling upside risk potential of 22.32%. On the other hand Enhabit, Inc. has an analysts' consensus of $9.75 which suggests that it could grow by 5.75%. Given that The Joint Corp. (United States) has higher upside potential than Enhabit, Inc., analysts believe The Joint Corp. (United States) is more attractive than Enhabit, Inc..

The Joint Corp. (United States) has a beta of 1.291, which suggesting that the stock is 29.096% more volatile than S&P 500. In comparison Enhabit, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

The Joint Corp. (United States) has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Enhabit, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Joint Corp. (United States) pays -- of its earnings as a dividend. Enhabit, Inc. pays out -- of its earnings as a dividend.

The Joint Corp. (United States) quarterly revenues are $13.4M, which are smaller than Enhabit, Inc. quarterly revenues of $263.6M. The Joint Corp. (United States)'s net income of $290.4K is lower than Enhabit, Inc.'s net income of $11.6M. Notably, The Joint Corp. (United States)'s price-to-earnings ratio is 75.63x while Enhabit, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Joint Corp. (United States) is 2.44x versus 0.45x for Enhabit, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

IQVIA Holdings, Inc. has a net margin of 2.17% compared to The Joint Corp. (United States)'s net margin of 8.1%. The Joint Corp. (United States)'s return on equity of -1.38% beat IQVIA Holdings, Inc.'s return on equity of 20.65%.

The Joint Corp. (United States) has a consensus price target of $10.67, signalling upside risk potential of 22.32%. On the other hand IQVIA Holdings, Inc. has an analysts' consensus of $253.95 which suggests that it could grow by 12.66%. Given that The Joint Corp. (United States) has higher upside potential than IQVIA Holdings, Inc., analysts believe The Joint Corp. (United States) is more attractive than IQVIA Holdings, Inc..

The Joint Corp. (United States) has a beta of 1.291, which suggesting that the stock is 29.096% more volatile than S&P 500. In comparison IQVIA Holdings, Inc. has a beta of 1.364, suggesting its more volatile than the S&P 500 by 36.392%.

The Joint Corp. (United States) has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IQVIA Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Joint Corp. (United States) pays -- of its earnings as a dividend. IQVIA Holdings, Inc. pays out -- of its earnings as a dividend.

The Joint Corp. (United States) quarterly revenues are $13.4M, which are smaller than IQVIA Holdings, Inc. quarterly revenues of $4.1B. The Joint Corp. (United States)'s net income of $290.4K is lower than IQVIA Holdings, Inc.'s net income of $332M. Notably, The Joint Corp. (United States)'s price-to-earnings ratio is 75.63x while IQVIA Holdings, Inc.'s PE ratio is 30.95x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Joint Corp. (United States) is 2.44x versus 2.49x for IQVIA Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

SCWorx Corp. has a net margin of 2.17% compared to The Joint Corp. (United States)'s net margin of -185.96%. The Joint Corp. (United States)'s return on equity of -1.38% beat SCWorx Corp.'s return on equity of -74.77%.

The Joint Corp. (United States) has a consensus price target of $10.67, signalling upside risk potential of 22.32%. On the other hand SCWorx Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that The Joint Corp. (United States) has higher upside potential than SCWorx Corp., analysts believe The Joint Corp. (United States) is more attractive than SCWorx Corp..

The Joint Corp. (United States) has a beta of 1.291, which suggesting that the stock is 29.096% more volatile than S&P 500. In comparison SCWorx Corp. has a beta of 2.027, suggesting its more volatile than the S&P 500 by 102.683%.

The Joint Corp. (United States) has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SCWorx Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Joint Corp. (United States) pays -- of its earnings as a dividend. SCWorx Corp. pays out -- of its earnings as a dividend.

The Joint Corp. (United States) quarterly revenues are $13.4M, which are larger than SCWorx Corp. quarterly revenues of $705.8K. The Joint Corp. (United States)'s net income of $290.4K is higher than SCWorx Corp.'s net income of -$1.3M. Notably, The Joint Corp. (United States)'s price-to-earnings ratio is 75.63x while SCWorx Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Joint Corp. (United States) is 2.44x versus 0.27x for SCWorx Corp.. Usually stocks with elevated PS ratios are considered overvalued.